DOSSIER · 13F-HR · Q2 2026

BARINGS LLC

$5.6B in tracked AUM across 245 positions as of Q2 2026.

BL
CIK 0000009015 · last filed Jun 30, 2026
Total AUM
$5.6B
as of Q2 2026
Holdings
245
positions
Whale Score
73
73
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026

Barings LLC entered 2026 with $6.19B in assets, roughly $760M more than it managed at year-end, and deployed a significant portion of that new capital into two corporate-bond ETFs — LQD and JAAA — in a move that now frames more than a quarter of the entire portfolio. The $938.7M LQD position nearly tripled in share terms (from 2.77M to 8.61M shares) and grew by $633M in market value to become the second-largest holding after IVV. JAAA, the Janus Henderson AAA CLO ETF, rose $347M to $650M — the second-largest single-quarter increase in the filing. Together those two credit-focused positions now represent over 25% of Barings' equity-book, concentrated in investment-grade corporate credit and AAA-rated collateralized loan obligations in a way that reflects a deliberate income-and-duration bet more than a passive allocation. On the equity side, QQQ entered as a new $503M position (Nasdaq-100 via Invesco's product), while the top S&P 500 core, IVV, was pared by $122M despite remaining the largest single holding at $1.06B. The filing also showed nine new names alongside nine sold positions, including rotation within equity sleeves: IW (iShares S&P 500 growth) exited while VTV entered, and within single-stock names AstraZeneca, Suncor, and Caterpillar-energy-adjacent names (EOG, Coterra) appeared while Freeport-McMoRan and Vale left. What is most striking about the portfolio is not that it rotates — active managers rotate — but that the story is almost entirely being told through ETFs: the top seven holdings are all ETFs, collectively accounting for roughly 71% of the book. That structure is coherent for a multi-strategy or fund-of-funds wrapper where ETFs are the primary sleeves, but it means the headline conviction signals are sleeve-rotation signals rather than single-name calls. The $760M AUM inflow alongside the aggressive credit build suggests investors put money to work in Barings specifically for its fixed-income and alternative-credit exposure, and this 13F shows the portfolio structure meeting that demand.

LQD, the iShares Investment Grade Corporate Bond ETF, moved from $305M to $939M — a $633M increase that required the share count to nearly quadruple, from 2.77M to 8.61M shares. That is an unusual statement of conviction in a single sleeve: bond ETFs do not usually see that kind of single-quarter expansion at a $600M-plus scale, and it points at a deliberate and sizable duration-plus-credit-rating tilt that Barings was building. JAAA, Janus Henderson's AAA-rated CLO ETF, added $347M to reach $650M — a 115% share-count increase from 6M to 12.9M shares — making the credit-income theme across both names a combined $1.59B, or roughly 26% of the total portfolio. Neither position would have appeared on a passive radar; both are product-specific calls on how Barings believes the rate and credit cycle will resolve.

On the equity side, QQQ entered as a new position at $503M, adding Barings' first significant Nasdaq-100 large-cap growth sleeve in recent memory. The $122M reduction in IVV, the S&P 500 ETF that had been the single largest holding at $1.06B, is consistent with that rotation — the portfolio is reloading its U.S. equity exposure through the more growth-concentrated Nasdaq index rather than the broader S&P. That is a deliberate tilt, not a passive maintenance decision. Within single-stock names, AstraZeneca entered at $28M alongside new positions in Suncor, EOG, Coterra, and Darling Ingredients, a cluster of energy-and-agriculture-adjacent names that reads like a commodity-exposure build rather than a coincidence. Freeport-McMoRan and Vale exited, which aligns with the rotation away from base-metals positioning.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
IVV
ISHARES TR
$1.3B1.7M23.2%
02
QQQ
INVESCO QQQ TR
$636M863K11.3%
03
IWO
ISHARES TR
$622M1.6M11.0%
04
VCSH
VANGUARD SCOTTSDALE FDS
$404M5.1M7.2%
05
IGSB
ISHARES TR
$358M6.8M6.4%
06
LQD
ISHARES TR
$297M2.7M5.3%
07
JAAA
JANUS DETROIT STR TR
$248M4.9M4.4%
08
BBDC
BARINGS BDC, INC.
$116M13.6M2.1%
09
VT
VANGUARD INTL EQUITY INDEX F
$115M733K2.0%
10
HLF 4.25 06/15/28
HERBALIFE LTD
$68M59.6M1.2%

Filing history

2026Q2Jun 30
$5.6B 9.0%
245 positionsView →
2026Q1Mar 31
$6.2B 14.1%
238 positionsView →
2025Q4Dec 31
$5.4B 3.3%
218 positionsView →
2025Q3Sep 30
$5.3B 22.6%
221 positionsView →
2025Q2Jun 30
$4.3B 6.9%
217 positionsLocked
2025Q1Mar 31
$4.0B 4.8%
210 positionsLocked
2024Q4Dec 31
$4.2B 1.7%
209 positionsLocked
2024Q3Sep 30
$4.3B 4.1%
197 positionsLocked
2024Q2Jun 30
$4.1B 3.2%
185 positionsLocked
2024Q1Mar 31
$4.0B 27.0%
206 positionsLocked
2023Q4Dec 31
$3.1B 7.0%
194 positionsLocked
2023Q3Sep 30
$2.9B 0.9%
202 positionsLocked
Showing 12 of 83